The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.

The partners will work together to explore the use of a technology from Fujirebio subsidiary Fluxus in infectious disease.

The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.

Company officials disclosed that it had been eyeing an out from Savanna in the potential acquisition of Lex Diagnostics for at least the past 18 months.